Restoring the functional immunogenicity of chronic lymphocytic leukemia using epigenetic modifiers
Keywords: 5-Aza-2â²-deoxycytidine; Cancer-germline; Immunotherapy; Histone deacetylase inhibitor; Costimulatory;